Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Q2

This article was originally published in The Tan Sheet

Executive Summary

July shipments of Ensure in "new, break-resistant and re-closable bottles" expected to drive category expansion and increase market share, firm says in July 10 Q2 sales and earnings announcement. Although Ross Products division's revenue fell 7.1% to $478 mil. in second quarter due to negative impact of "pricing pressures in the institutional segment of medical nutritionals" and recent divestitures, Abbott anticipates Ross' overall sales in second half of 2003 will be flat or slightly up. Overall, Abbott reported Q2 earnings down 58% to $247 mil. due to one-time $622 mil. charge taken in the quarter to settle charges against Ross' enteral nutrition division (1"The Tan Sheet" Jan. 30, 2003, In Brief)...

You may also be interested in...



Abbott settlement

Firm will record one-time charge of $622 mil. in Q2 in anticipation of a settlement of civil and criminal charges related to sales and marketing practices by firm's Ross Products enteral nutrition division. Charges stemmed from industry-wide investigation of the enteral nutrition sector, initiated in the mid-1990's by the U.S. Attorney's office in the Southern District of Illinois. Investigation reportedly involved allegations of kickbacks in the form of discounted or free enteral pumps being supplied in exchange for disposable pump set supply contracts with providers; charges for such pumps may have been passed on to Medicare and Medicaid. "The anticipated settlement will resolve all outstanding allegations by the government," including "all federal and state Medicare and Medicaid issues," Abbott says in June 26 release...

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel